Research progress in inducing immunogenic cell death of tumor cells

D Xie, Q Wang, G Wu - Frontiers in immunology, 2022 - frontiersin.org
Immunogenic cell death (ICD) is a regulated cell death (RCD) pathway. In response to
physical and chemical signals, tumor cells activate specific signaling pathways that stimulate …

Design of smart nanomedicines for effective cancer treatment

NH Aghda, M Dabbaghianamiri, JW Tunnell… - International Journal of …, 2022 - Elsevier
Nanomedicine is a novel field of study that involves the use of nanomaterials to address
challenges and issues that are associated with conventional therapeutics for cancer …

[HTML][HTML] Recent advances of nanobubble-based systems in cancer therapeutics: A Review

D Dehariya, K Eswar, A Tarafdar, S Balusamy… - Biomedical Engineering …, 2023 - Elsevier
Cancer is characterized by the uncontrolled growth of cells that also metastasis, owing to the
mutation in p53 (tumor suppressor gene), making cancer a deadly disease. Though …

Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics

J Ramon, Y Engelen, H De Keersmaecker… - Journal of Controlled …, 2024 - Elsevier
The most lethal form of skin cancer is cutaneous melanoma, a tumor that develops in the
melanocytes, which are found in the epidermis. The treatment strategy of melanoma is …

Enhanced drug delivery with nanocarriers: a comprehensive review of recent advances in breast cancer detection and treatment

R Dhiman, N Bazad, R Mukherjee, Himanshu, Gunjan… - Discover Nano, 2024 - Springer
Breast cancer (BC) remains a leading cause of morbidity and mortality among women
worldwide, with triple-negative breast cancer (TNBC) posing significant treatment …

Promotion of ICD via Nanotechnology

Y Qin, H Zhang, Y Li, T Xie, S Yan… - Macromolecular …, 2023 - Wiley Online Library
Immunotherapy represents the most promising treatment strategy for cancer, but suffers from
compromised therapeutic efficiency due to low immune activity of tumor cells and an …

Comprehensive review of drug-mediated ICD inhibition of breast cancer: mechanism, status, and prospects

Y Wang, R Yang, Y Xie, XQ Zhou, JF Yang… - Clinical and …, 2024 - Springer
The escalating incidence of breast cancer (BC) in women underscores its grave health
threat. Current molecular insights into BC's post-adjuvant therapy cure remain elusive …

Part II. Nanobubbles around plasmonic nanoparticles in terms of modern simulation modeling: what makes them kill the malignant cells?

AS Kostyukov, IL Isaev, AE Ershov… - Journal of Physics D …, 2022 - iopscience.iop.org
We have established numerically the physical pattern and conditions for formation of
nanosized bubbles in aqueous medium around biocompatible plasmonic nanoparticles …

Enhancing Breast Cancer Therapy: Nanocarrier-Based Targeted Drug Delivery

R Pandey, R Dhiman, N Bazad, R Mukerjee, J Vidic… - 2023 - preprints.org
Breast cancer (BC) is one of the most common types of cancer in women. Triple-negative
breast cancer (TNBC), characterized by the absence of estrogen receptor (ER) …

[PDF][PDF] Discover Nano

K Kaur, VS Raj, CM Chang, RP Pandey - 2024 - researchgate.net
Breast cancer (BC) remains a leading cause of morbidity and mortality among women
worldwide, with triple-negative breast cancer (TNBC) posing significant treatment …